FOGHORN THERAPEUTICS INC (FHTX) Forecast, Price Target & Analyst Ratings

NASDAQ:FHTX • US3441741077

Current stock price

4.93 USD
+0.03 (+0.61%)
At close:
4.93 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FOGHORN THERAPEUTICS INC (FHTX).

Forecast Snapshot

Consensus Price Target

Price Target
$11.86
+ 140.52% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
7.298M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.86
Upside
+ 140.52%
From current price of $4.93 to mean target of $11.86, Based on 16 analyst forecasts
Low
$9.09
Median
$12.24
High
$14.70

Price Target Revisions

1 Month
2.57%
3 Months
4.33%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for FHTX. The average price target is 11.86 USD. This implies a price increase of 140.52% is expected in the next year compared to the current price of 4.93.
The average price target has been revised upward by 4.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FHTX Current Analyst RatingFHTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

FHTX Historical Analyst RatingsFHTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
87.50%
FHTX was analyzed by 16 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about FHTX.
In the previous month the buy percentage consensus was at a similar level.
FHTX was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-12WedbushReiterate Outperform -> Outperform
2026-03-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-17JefferiesMaintains Buy -> Buy
2025-12-18BTIGInitiate Buy
2025-12-04StifelInitiate Buy
2025-11-07GuggenheimInitiate Buy
2025-05-15JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-04-30JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-04-30HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-23JMP SecuritiesInitiate Market Outperform
2025-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-30B. Riley SecuritiesInitiate Buy
2024-12-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-16JefferiesMaintains Buy -> Buy
2024-09-24Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2024-09-03JefferiesInitiate Buy
2024-08-19Evercore ISI GroupInitiate Outperform
2024-08-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-09WedbushReiterate Outperform -> Outperform
2024-05-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-01HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-10WedbushReiterate Outperform -> Outperform
2024-04-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-08WedbushReiterate Outperform -> Outperform
2023-11-13Morgan StanleyMaintains Equal-Weight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
7.298M
Revenue Q2Q
22.61%
EPS Q2Q
-1.58%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
6.15%
Revenue (3 Months)
9.63%
EPS (1 Month)
-3.53%
EPS (3 Months)
4.15%

Next Earnings Summary

FHTX is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 7.30M USD.
The next earnings revenue estimate has been revised upward by 9.63% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FHTX revenue by date.FHTX revenue by date.
34.155M
77.61%		22.602M
-33.83%		30.909M
36.75%		33.323M
7.81%		39.229M
17.72%		42.773M
9.03%		62.07M
45.11%		125.31M
101.88%		184.5M
47.23%		218.91M
18.65%		422.31M
92.91%
EBITDA
YoY % growth
FHTX ebitda by date.FHTX ebitda by date.
-104.455M
8.24%		-97.165M
6.98%		-78.775M
18.93%		-104.742M
-32.96%		-83.977M
19.83%		N/A-135.364M-133.151M
1.64%		-20.012M
84.97%		46.971M
334.71%		107.7M
129.29%
EBIT
YoY % growth
FHTX ebit by date.FHTX ebit by date.
-107.906M
7.88%		-100.285M
7.06%		-82.107M
18.13%		-87.238M
-6.25%		-91.53M
-4.92%		-100.289M
-9.57%		-95.534M
4.74%		-51.038M
46.58%		-5.649M
88.93%		13.376M
336.77%		170.1M
1,171.68%
Operating Margin
FHTX operating margin by date.FHTX operating margin by date.
-315.93%-443.70%-265.64%-261.80%-233.32%-234.47%-153.91%-40.73%-3.06%6.11%40.28%
EPS
YoY % growth
FHTX eps by date.FHTX eps by date.
-2.34
10.69%		-1.65
29.49%		-1.17
29.09%		-1.07
8.27%		-1.12
-4.15%		-0.81
27.55%		-0.74
8.43%		0.06
108.25%		0.59
860.00%		0.58
-0.61%		2.87
390.83%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.30
-1.58%		-0.29
-3.37%		-0.28
-11.69%		-0.27
19.38%		-0.39
-26.86%		-0.39
-36.04%		-0.40
-44.29%		-0.41
-49.95%		-0.42
-8.44%		-0.43
-8.55%		-0.44
-8.61%		-0.45
-8.68%
Revenue
Q2Q % growth		7.298M
22.61%		7.666M
1.44%		7.916M
-2.91%		8.244M
-10.85%		N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-25.188M
-14.05%		-25.36M
-30.59%		-24.503M
-53.42%		-29.466M
-81.17%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-23.346M
-1.89%		-23.721M
-12.44%		-23.602M
-27.57%		-25.151M
-28.35%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FHTX Yearly Revenue VS EstimatesFHTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
FHTX Yearly EPS VS EstimatesFHTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.36%
EPS Next 5 Year
15.46%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.34%
Revenue Next 5 Year
31.52%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
-10.30%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FOGHORN THERAPEUTICS INC / FHTX Forecast FAQ

What do analysts expect the price target to be for FOGHORN THERAPEUTICS INC (FHTX)?

16 analysts have analysed FHTX and the average price target is 11.86 USD. This implies a price increase of 140.52% is expected in the next year compared to the current price of 4.93.

Can you provide the upcoming earnings date for FOGHORN THERAPEUTICS INC?

FOGHORN THERAPEUTICS INC (FHTX) will report earnings on 2026-05-12, before the market open.

What are the consensus estimates for FOGHORN THERAPEUTICS INC (FHTX) next earnings?

The consensus EPS estimate for the next earnings of FOGHORN THERAPEUTICS INC (FHTX) is -0.3 USD and the consensus revenue estimate is 7.30M USD.

Can you provide the expected long term growth rate for FOGHORN THERAPEUTICS INC stock?

The expected long term growth rate for FOGHORN THERAPEUTICS INC (FHTX) is 10.34%.